Search
Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Tech, tests and treatments to aid Coronavirus control and cure efforts

With the largest particle accelerator in the southern hemisphere, Australia could hold the key to fast-tracking the development of a vaccine for coronavirus.

Called Synchrotron, the particle accelerator allows researchers to see the structure of key proteins in a virus and how they interact with other molecules. This ability will be extremely advantageous in the development of a vaccine or treatment regimen.

I get a sound understanding of the positions of critical components of these proteins, companies can develop drugs that bind to these proteins and potentially prevent or treat disease.

“You need to know what the protein looks like so you can design a drug to attach to it,” Synchrotron director Professor Andrew Peele said. “It’s like designing a key for a lock, you need to know the dimensions of the keyhole.”

While many proteins in the virus have already been mapped, researchers from Australia’s Nuclear Science and Technology Organisation are constructing molecular structures of COVID-19 proteins. Once established, the clear 3D image will be made available to other coronavirus researchers.

In the meantime, the British Government aims to have millions of rapid detection coronavirus tests available in pharmacies and online stores. These tests can detect coronavirus antibodies from a self-administered finger prick.

Researchers at a leading university are completing work on a new test that can detect whether someone has already beaten the virus.

While the test does not detect whether someone is currently infected with the virus, it can determine if a person has already had the virus and recovered.

Initially, the tests will be reserved for hospital patients, health care staff and other essential workers, but will eventually be available for the general public to test themselves.

The tests are aimed at detecting which people have already had coronavirus and recovered from it so that they can return to work and go back to living their lives.

Japan is also driving efforts to find drugs that could cure COVID-19 patients from unlikely players.

Japan’s health minister, Katsunobu Kato, had enlisted Fujifilm, a camera and imaging company, to help fight COVID-19.

Kato hopes to use an existing drug could be used to treat patients. One candidate was an anti-influenza drug, which had been developed decades earlier by the Fujifilm subsidiary Toyama Chemical.

Working incessantly, the team drew up contingency plans for ramping up production of the drug, coordinated with clinical researchers throughout Japan and aided in getting the drug to hospitals where its use had been approved by the government as an emergency measure to treat dozens of COVID-19 patients.

While there is not yet any detailed data supporting the drug’s effectiveness as a COVID-19 treatment, there are some reasons for optimism. At least one of the clinical trials will conclude at the end of June and will provide much-needed data.

According to a recent report, Fujifilm has discussed the possibility of the drug’s trials in the US with the FDA and the US Department of Health and Human Services.

While most countries have imposed versions of a lockdown, they are also exploring every avenue that could lead to a diagnostic, treatment and/or vaccine.

Countries across the world are working overtime to get solutions to combat the COVID-19 pandemic deploying technology and tool as best they can.

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.